Connect With Us
Describe your need or issue with us and a Kinexum representative will be in touch with you shortly to discuss how we might be able to assist you.
Mitchell R. Smith, MD, PhD has been the Chief Medical Officer of the UK-based non-profit Follicular Lymphoma Foundation since mid-2021.
Dr. Smith’s experience is broad and spans a number of years: He joined the GWU Cancer Center in Washington DC in 2017 as Associate Cancer Center Director for Clinical Investigations, as well as Chief of the Division of Oncology & Blood Disorders. Prior to that he was the Director of the Lymphoid Malignancy Program at the Cleveland Clinic. After serving as Assistant Professor in Medical Oncology at Wayne State University in Detroit, MI, he joined Fox Chase Cancer Center in 1993, where he remained as Director of the Lymphoma Program until 2012. His clinical and laboratory interests have focused on targeted approaches to improve therapy of lymphoid malignancies, with a focus on mantle cell lymphoma. He has been involved in numerous clinical trials of targeted therapies, including CART cells, in lymphoma, leukemia and myeloma.
Dr. Smith earned his Medical Degree and PhD at Case Western Reserve University School of Medicine, Cleveland, OH. He completed an internship in Internal Medicine at the Long Island Jewish Hospital, NY, spent 3 years as a Resident in Pathology at Washington University – Barnes Hospital, in St. Louis, MO, then another year as a Resident in Internal Medicine at the Jewish Hospital of St. Louis, MO. His Fellowship in Medical Oncology was at Memorial Sloan-Kettering Cancer Center, NY where he also was a Fellow in Biomedical Research in the Clinical Scholars Program.
Dr. Smith is an active member of the ASCO, AACR, ASH and ECOG. He has served on the NCCN lymphoma and myeloma guideline committees and chaired the Mantle Cell Lymphoma subcommittee of the NCTN lymphoma planning committee.